Suntrust Banks’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q3 | $3.69M | Sell |
29,817
-41,697
| -58% | -$5.16M | 0.02% | 411 |
|
2019
Q2 | $10.1M | Buy |
71,514
+12,365
| +21% | +$1.74M | 0.05% | 242 |
|
2019
Q1 | $8.92M | Buy |
59,149
+182
| +0.3% | +$27.5K | 0.05% | 245 |
|
2018
Q4 | $7.32M | Buy |
58,967
+24,567
| +71% | +$3.05M | 0.04% | 253 |
|
2018
Q3 | $5.45M | Buy |
34,400
+23,092
| +204% | +$3.66M | 0.03% | 306 |
|
2018
Q2 | $1.58M | Buy |
11,308
+254
| +2% | +$35.6K | 0.01% | 611 |
|
2018
Q1 | $1.47M | Buy |
11,054
+2,188
| +25% | +$291K | 0.01% | 620 |
|
2017
Q4 | $1.11M | Buy |
8,866
+134
| +2% | +$16.7K | 0.01% | 669 |
|
2017
Q3 | $1.08M | Buy |
8,732
+352
| +4% | +$43.6K | 0.01% | 708 |
|
2017
Q2 | $955K | Buy |
8,380
+772
| +10% | +$88K | 0.01% | 665 |
|
2017
Q1 | $802K | Sell |
7,608
-18,066
| -70% | -$1.9M | 0.01% | 702 |
|
2016
Q4 | $2.33M | Sell |
25,674
-13,275
| -34% | -$1.21M | 0.01% | 503 |
|
2016
Q3 | $3.88M | Sell |
38,949
-1,778
| -4% | -$177K | 0.02% | 347 |
|
2016
Q2 | $3.64M | Buy |
40,727
+619
| +2% | +$55.4K | 0.02% | 346 |
|
2016
Q1 | $3.51M | Sell |
40,108
-9,295
| -19% | -$814K | 0.02% | 332 |
|
2015
Q4 | $5.58M | Buy |
49,403
+3,554
| +8% | +$402K | 0.03% | 246 |
|
2015
Q3 | $4.64M | Buy |
45,849
+8,605
| +23% | +$872K | 0.03% | 259 |
|
2015
Q2 | $4.62M | Buy |
37,244
+1,387
| +4% | +$172K | 0.03% | 267 |
|
2015
Q1 | $4.24M | Buy |
35,857
+2,499
| +7% | +$295K | 0.03% | 281 |
|
2014
Q4 | $3.4M | Buy |
33,358
+1,146
| +4% | +$117K | 0.02% | 302 |
|
2014
Q3 | $2.96M | Buy |
32,212
+3,241
| +11% | +$297K | 0.02% | 345 |
|
2014
Q2 | $2.39M | Buy |
28,971
+3,030
| +12% | +$249K | 0.02% | 406 |
|
2014
Q1 | $1.99M | Buy |
25,941
+6,802
| +36% | +$522K | 0.01% | 676 |
|
2013
Q4 | $1.32M | Buy |
19,139
+3,835
| +25% | +$265K | 0.01% | 815 |
|
2013
Q3 | $991K | Buy |
15,304
+3,730
| +32% | +$242K | ﹤0.01% | 892 |
|
2013
Q2 | $673K | Buy |
+11,574
| New | +$673K | ﹤0.01% | 1021 |
|